Jill Cook Selected Research

Tendinopathy (Tendonitis)

5/2021	Association Between COL5a1, COL11a1, and COL11a2 Gene Variations and Rotator Cuff Tendinopathy in Young Athletes.
1/2021	Ciprofloxacin reduces tenocyte viability and proteoglycan synthesis in short-term explant cultures of equine tendon.
12/2019	High-energy dose of therapeutic ultrasound in the treatment of patellar tendinopathy: protocol of a randomized placebo-controlled clinical trial.
1/2019	Extracorporeal Shock Wave Therapy Immediately Affects Achilles Tendon Structure and Widespread Pressure Pain Thresholds in Healthy People: A Repeated-Measures Observational Study.
5/2017	Isometric Contractions Are More Analgesic Than Isotonic Contractions for Patellar Tendon Pain: An In-Season Randomized Clinical Trial.
2/2016	Tendon neuroplastic training: changing the way we think about tendon rehabilitation: a narrative review.
10/2015	Isometric exercise induces analgesia and reduces inhibition in patellar tendinopathy.
6/2015	Extracellular matrix proteins interact with cell-signaling pathways in modifying risk of achilles tendinopathy.
7/2014	The Bonar score revisited: region of evaluation significantly influences the standardized assessment of tendon degeneration.
5/2014	Fluoroquinolones and tendinopathy: a guide for athletes and sports clinicians and a systematic review of the literature.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jill Cook Research Topics

Disease

18	Tendinopathy (Tendonitis) 05/2021 - 07/2005
9	Pain (Aches) 07/2022 - 01/2014
3	Rupture 01/2021 - 08/2011
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Hyperalgesia 01/2019
1	Reinjuries 11/2016
1	Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos) 11/2013
1	Atrophy 11/2013
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2011

Drug/Important Bio-Agent (IBA)

5	CollagenIBA 05/2021 - 05/2009
4	Proteoglycans (Proteoglycan)IBA 01/2021 - 05/2009
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 05/2014
2	FluoroquinolonesIBA 01/2021 - 05/2014
2	Extracellular Matrix ProteinsIBA 06/2015 - 08/2011
2	Messenger RNA (mRNA)IBA 01/2012 - 05/2009
1	Pain-FreeIBA 07/2022
1	Aggrecans (Aggrecan)IBA 01/2021
1	Versicans (Versican)IBA 01/2021
1	BiglycanIBA 01/2021
1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	Analgesics (Analgesic Drugs)IBA 05/2017
1	Hormones (Hormone)IBA 01/2016
1	mahuang-tangIBA 01/2016
1	GlycosaminoglycansIBA 07/2014
1	QuinolonesIBA 05/2014
1	Cartilage Oligomeric Matrix ProteinIBA 01/2014
1	Biological ProductsIBA 01/2014
1	Ion Channels (Ion Channel)IBA 01/2014
1	ProcollagenIBA 11/2013
1	PuromycinIBA 11/2013
1	Proteins (Proteins, Gene)FDA Link 11/2013
1	Collagen Type I (Type I Collagen)IBA 11/2013
1	Collagen Type XIIBA 06/2013
1	CytokinesIBA 01/2012
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2012
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2012
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 10/2011
1	Interleukin-6 (Interleukin 6)IBA 10/2011
1	Peptide Hydrolases (Proteases)FDA Link 10/2010

Therapy/Procedure

3	Analgesia 05/2017 - 10/2015
2	Extracorporeal Shockwave Therapy 01/2019 - 01/2007
2	Resistance Training 02/2016 - 10/2015
1	Ultrasonic Therapy 12/2019
1	Tertiary Prevention 11/2016
1	Therapeutics 01/2016
1	Exercise Therapy (Therapy, Exercise) 01/2016
1	Complementary Therapies (Alternative Medicine) 05/2014
1	Conservative Treatment 07/2005